Login / Signup

The provisional OMERACT ultrasonography score for giant cell arteritis.

Christian DejacoCristina PonteSara MontiDavide RozzaAnd Carlo Alberto ScirèLene TerslevGeorge A W BruynDennis BoumansWolfgang HartungAlojzija HocevarMarcin MilchertUffe Møller DøhnChetan B MukhtyarMarkus AschwandenPhilipp BoschDario CamellinoStavros ChrysidisGiovanni CiancioMaria Antonietta D'AgostinoThomas DaikelerBhaskar DasguptaEugenio de MiguelAndreas P DiamantopoulosChristina DuftnerAna AguedaUlrich FredbergPetra HanovaIb Tønder HansenEllen-Margrethe HaugeAnnaMaria IagnoccoGüzide Nevsun İnançAaron JucheRositsa Valerieva KaralilovaToshio KawamotoKresten Krarup KellerHelen Isobel KeenTanaz A KermaniMinna J KohlerMatthew J KosterRaashid Ahmed LuqmaniPierluigi MacchioniSarah Louise MackieEsperanza NaredoBerit Dalsgaard NielsenMichihiro OgasawaraCarlos Javier Pineda-VillaseñorValentin Sebastian SchäferLuca SeitzAlessandro TomelleriKarina D TorralbaKornelis S M van der GeestKenneth J WarringtonWolfgang Andreas Schmidt
Published in: Annals of the rheumatic diseases (2022)
We developed a provisional OGUS for potential use in clinical trials.
Keyphrases
  • giant cell
  • clinical trial
  • magnetic resonance imaging
  • contrast enhanced
  • phase ii
  • human health
  • open label
  • randomized controlled trial
  • computed tomography
  • magnetic resonance
  • phase iii
  • double blind
  • risk assessment